Trial Profile
A 3-month, open-label, pharmacy-based, actual-use trial in a simulated over-the-counter (OTC) environment to assess self-selection and consumer use patterns of gabapentin 250 mg for occasional sleeplessness
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Pfizer
- 06 May 2008 New trial record.